AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1461854 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cm incision
Number of subjects: 30
Study 1461854 — intervention group
Group type: COMPARATOR
Intervention: 15 cm incision
Number of subjects: 30
Study 6386694 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytetracycline
Number of subjects: 45
Study 6386694 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 45
Study 30676816 — intervention group
Group type: EXPERIMENTAL
Intervention: UKtest
Number of subjects: 12
Study 29253140 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 g of retraction force
Number of subjects: 20
Study 29253140 — intervention group
Group type: COMPARATOR
Intervention: 180 g of retraction force
Number of subjects: 20
Study 26255618 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cochlear implantation
Number of subjects: 38
Study 26255618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral cochlear implantation
Number of subjects: 38
Study 26255618 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-implantation)
Number of subjects: 38
Study 25282679 — intervention group
Group type: EXPERIMENTAL
Intervention: Active scapular correction
Number of subjects: 23
Study 25282679 — intervention group
Group type: COMPARATOR
Intervention: Passive scapular correction
Number of subjects: 23
Study 22751877 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia treatment
Number of subjects: 127
Study 22751877 — intervention group
Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 127
Study 19597072 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified directly observed therapy (mDOT) for 24 weeks
Number of subjects: 243
Study 19597072 — intervention group
Group type: COMPARATOR
Intervention: Self-administered therapy
Number of subjects: 243
Study 19597072 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified directly observed therapy (mDOT) for 48 weeks
Number of subjects: 243
Study 17142385 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg once daily
Number of subjects: 997
Study 17142385 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 997
Study 15118192 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Recovery (AR) - cycling at 40% VO(2peak) during a 15-min recovery period
Number of subjects: 7
Study 15118192 — intervention group
Group type: COMPARATOR
Intervention: Passive Recovery (PR) - resting supine during a 15-min recovery period
Number of subjects: 7
Study 15118192 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AR and PR
Number of subjects: 7
Study 11387501 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups combined
Number of subjects: 15116
Study 11387501 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups combined (after adjustment for case mix)
Number of subjects: 15116
Study 9738178 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially prepared solid foods from 3 to 12 months
Number of subjects: 165
Study 9738178 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent's choice of solid foods from 3 to 12 months
Number of subjects: 165
Study 9738178 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially prepared solid foods from 6 to 12 months
Number of subjects: 165
Study 9738178 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent's choice of solid foods from 6 to 12 months
Number of subjects: 165
Study 9738178 — intervention group
Group type: EXPERIMENTAL
Intervention: Early introduction of solid foods
Number of subjects: 165
Study 9738178 — intervention group
Group type: COMPARATOR
Intervention: Late introduction of solid foods
Number of subjects: 165
Study 7774451 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin solution (25U/ml) irrigated during operation
Number of subjects: 47
Study 7774451 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heparin solution)
Number of subjects: 47
Study 3245859 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% desonide cream
Number of subjects: 0
Study 3245859 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% halometasone cream
Number of subjects: 0
Study 3245859 — intervention group
Group type: COMPARATOR
Intervention: 0.05% clobetasol 17‐propionate cream
Number of subjects: 0
Study 3245859 — intervention group
Group type: COMPARATOR
Intervention: 0.1% betamethasone 17‐valerate cream
Number of subjects: 0
Study 3245859 — intervention group
Group type: COMPARATOR
Intervention: 0.05% clobetasone 17‐butyrate cream
Number of subjects: 0
Study 29199540 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES group, Tetraspan®)
Number of subjects: 40
Study 29199540 — intervention group
Group type: COMPARATOR
Intervention: Acetated Ringer's solution (CT group)
Number of subjects: 40
Study 26473652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreaticojejunostomy (PJ)
Number of subjects: 136
Study 26473652 — intervention group
Group type: COMPARATOR
Intervention: Stapler closure
Number of subjects: 136
Study 26473652 — intervention group
Group type: COMPARATOR
Intervention: Stapler closure (subgroup analysis for thickness of pancreas > 12mm)
Number of subjects: 136
Study 23900983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryobiopsy
Number of subjects: 39
Study 23900983 — intervention group
Group type: COMPARATOR
Intervention: Forceps biopsy
Number of subjects: 39
Study 22653816 — intervention group
Group type: EXPERIMENTAL
Intervention: Strictly-guided, station-based laboratory sessions
Number of subjects: 360
Study 22653816 — intervention group
Group type: COMPARATOR
Intervention: Loosely-guided laboratory sessions
Number of subjects: 360
Study 19866382 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulated study (item selection and study time)
Number of subjects: 0
Study 19866382 — intervention group
Group type: EXPERIMENTAL
Intervention: Study time allocation
Number of subjects: 0
Study 19866382 — intervention group
Group type: EXPERIMENTAL
Intervention: Study performance
Number of subjects: 0
Study 19866382 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory self-efficacy and perceived control
Number of subjects: 0
Study 18855180 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative reminiscence
Number of subjects: 106
Study 18855180 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 106
Study 16650239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 89
Study 16650239 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 89
Study 14649617 — intervention group
Group type: EXPERIMENTAL
Intervention: Concise
Number of subjects: 120
Study 14649617 — intervention group
Group type: COMPARATOR
Intervention: Optibond system
Number of subjects: 120
Study 14649617 — intervention group
Group type: COMPARATOR
Intervention: Optibond system plus Concise
Number of subjects: 120
Study 14649617 — intervention group
Group type: EXPERIMENTAL
Intervention: Concise on wet saliva-contaminated surfaces
Number of subjects: 120
Study 10821345 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II antagonists (AIIA) monotherapy
Number of subjects: 11281
Study 10821345 — intervention group
Group type: EXPERIMENTAL
Intervention: AIIA dose titration
Number of subjects: 11281
Study 10821345 — intervention group
Group type: EXPERIMENTAL
Intervention: AIIA combined with low-dose hydrochlorothiazide (HCTZ)
Number of subjects: 11281
Study 10821345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11281
Study 10821345 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive classes
Number of subjects: 11281
Study 8629606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (1-25 cigarettes per day)
Number of subjects: 348874
Study 8629606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (>= 26 cigarettes per day)
Number of subjects: 348874
Study 8629606 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 348874
Study 8629606 — intervention group
Group type: COMPARATOR
Intervention: Black race
Number of subjects: 348874
Study 8629606 — intervention group
Group type: COMPARATOR
Intervention: Serum cholesterol (10 mg/dl higher)
Number of subjects: 348874
Study 1452929 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg)
Number of subjects: 18
Study 1452929 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10 mg) plus aspirin (350 mg)
Number of subjects: 18
Study 1452929 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10 mg) with placebo
Number of subjects: 18
Study 1452929 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg) without aspirin
Number of subjects: 18
Study 3969190 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (2,000 units) added to the second cycle
Number of subjects: 20
Study 31349796 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Protocolized Discontinuation (SPD) and Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0
Study 31349796 — intervention group
Group type: COMPARATOR
Intervention: Supported Protocolized Discontinuation (SPD) alone
Number of subjects: 0
Study 29603842 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg 1.0 g/kg
Number of subjects: 0
Study 29603842 — intervention group
Group type: COMPARATOR
Intervention: IVIg 0.5 g/kg
Number of subjects: 0
Study 29603842 — intervention group
Group type: COMPARATOR
Intervention: IVIg 2.0 g/kg
Number of subjects: 0
Study 26764586 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 99
Study 26764586 — intervention group
Group type: EXPERIMENTAL
Intervention: High emotion dysregulation
Number of subjects: 99
Study 26764586 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills use
Number of subjects: 99
Study 24309370 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide plus cisplatin (n=129)
Number of subjects: 258
Study 24309370 — intervention group
Group type: COMPARATOR
Intervention: Irinotecan plus cisplatin (n=129)
Number of subjects: 258
Study 22152080 — intervention group
Group type: EXPERIMENTAL
Intervention: Static handgrip exercise (HG)
Number of subjects: 8
Study 22152080 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined condition (HG + CPT)
Number of subjects: 8
Study 22152080 — intervention group
Group type: COMPARATOR
Intervention: Cold pressor test (CPT)
Number of subjects: 8
Study 20458641 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterolateral minimally invasive approach
Number of subjects: 44
Study 20458641 — intervention group
Group type: COMPARATOR
Intervention: Modified direct lateral approach
Number of subjects: 44
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetization Transfer Ratio (MTR)
Number of subjects: 18
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain (WB) volume
Number of subjects: 18
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal (Hc) mean MTR
Number of subjects: 18
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal (Hc) volume
Number of subjects: 18
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Histogram analysis of WB MTR
Number of subjects: 18
Study 17494679 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain (WB) volume and mean MTR
Number of subjects: 18
Study 16683454 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty in patients with ankylosing spondylitis
Number of subjects: 13
Study 16683454 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty in patients with non-ankylosing spondylitis
Number of subjects: 13
Study 12785624 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher frequency tutoring (one 45‐min. session every 1.6 days)
Number of subjects: 0
Study 12785624 — intervention group
Group type: COMPARATOR
Intervention: Lower frequency tutoring (one 45‐min. session every 8.3 days)
Number of subjects: 0
Study 12785624 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (higher and lower frequency)
Number of subjects: 0
Study 12785624 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with verbal ability scores one or two standard deviations below the population mean
Number of subjects: 0
Study 12785624 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of work on sounding and blending drill
Number of subjects: 0
Study 11077511 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle advice against smoking
Number of subjects: 0
Study 11077511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice (increased intake of grain products, vegetables, fruit, poultry, and fish)
Number of subjects: 0
Study 11077511 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice about exercise
Number of subjects: 0
Study 8971230 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Number of subjects: 139
Study 8971230 — intervention group
Group type: COMPARATOR
Intervention: Seated immersion
Number of subjects: 139
Study 8971230 — intervention group
Group type: COMPARATOR
Intervention: Land exercise
Number of subjects: 139
Study 8971230 — intervention group
Group type: COMPARATOR
Intervention: Progressive relaxation
Number of subjects: 139
Study 1731030 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular diphtheria-tetanus-pertussis vaccine and Haemophilus influenzae type b conjugate vaccine given at separate injection sites
Number of subjects: 79
Study 1731030 — intervention group
Group type: COMPARATOR
Intervention: Acellular diphtheria-tetanus-pertussis vaccine and Haemophilus influenzae type b conjugate vaccine given at a single site
Number of subjects: 79
Study 3882356 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of preoperatively applied ceftriaxon intravenously at the beginning of anesthesia
Number of subjects: 180
Study 3882356 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic at all (control group)
Number of subjects: 180
Study 31899170 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose behavioral coaching (16 sessions over 24 months)
Number of subjects: 317
Study 31899170 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose behavioral coaching (32 sessions over 24 months)
Number of subjects: 317
Study 31899170 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose behavioral coaching (48 sessions over 24 months)
Number of subjects: 317
Study 31899170 — intervention group
Group type: COMPARATOR
Intervention: Education-only comparator (16 sessions of nutrition education without coaching)
Number of subjects: 317
Study 30991881 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based aerobic training (WA)
Number of subjects: 69
Study 30991881 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based resistance training (WR)
Number of subjects: 69
Study 30991881 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 29231427 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture combined with rehabilitation training
Number of subjects: 74
Study 29231427 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training alone
Number of subjects: 74
Study 25448092 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03‐adjuvanted A/turkey/Turkey/1/05 H5N1 vaccine (3.75 or 7.5 μg HA)
Number of subjects: 841
Study 25448092 — intervention group
Group type: COMPARATOR
Intervention: AS03A‐adjuvanted booster vaccine (3.75 μg HA)
Number of subjects: 841
Study 23271615 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole apples (550 g/day)
Number of subjects: 23
Study 23271615 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple pomace (22 g/day)
Number of subjects: 23
Study 23271615 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloudy apple juice (500 ml/day)
Number of subjects: 23
Study 23271615 — intervention group
Group type: COMPARATOR
Intervention: Clear apple juice (500 ml/day)
Number of subjects: 23
Study 23271615 — intervention group
Group type: COMPARATOR
Intervention: No supplement
Number of subjects: 23
Study 21586238 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial liver support system (plasma exchange combined with continuous veno-venous hemodiafiltration, PE + CVVHDF)
Number of subjects: 81
Study 21586238 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 81
Study 18466617 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate exit cards
Number of subjects: 150
Study 18466617 — intervention group
Group type: COMPARATOR
Intervention: Delayed telephone follow-up surveys
Number of subjects: 150
Study 16594943 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day donepezil
Number of subjects: 12
Study 15329003 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 76
Study 15329003 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 76
Study 15329003 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 76
Study 11087280 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT-A)
Number of subjects: 40
Study 11087280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9357934 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-min infusion of 10 cal/oz formula
Number of subjects: 14
Study 9357934 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-min infusion of 20 cal/oz formula
Number of subjects: 14
Study 9357934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus feeding of 20 cal/oz formula over 15 min
Number of subjects: 14
Study 9357934 — intervention group
Group type: EXPERIMENTAL
Intervention: Water and half-strength formula as slow infusion
Number of subjects: 14
Study 9357934 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-strength formula as slow infusion
Number of subjects: 14
Study 1605959 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids + acyclovir (intravenous doses for Ramsay Hunt's syndrome)
Number of subjects: 45
Study 1605959 — intervention group
Group type: COMPARATOR
Intervention: Steroids (control group for Bell's palsy)
Number of subjects: 45
Study 1605959 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (oral doses for Bell's palsy)
Number of subjects: 45
Study 4072592 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 10 mg/kg
Number of subjects: 82
Study 4072592 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophenazone 4 mg/kg and Diazepam 0.2 mg/kg
Number of subjects: 82
Study 29359279 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose baclofen
Number of subjects: 0
Study 29359279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28692770 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping TNFi
Number of subjects: 817
Study 28692770 — intervention group
Group type: COMPARATOR
Intervention: Continuing TNFi
Number of subjects: 817
Study 27157032 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD load group
Number of subjects: 56
Study 27157032 — intervention group
Group type: COMPARATOR
Intervention: ASD no load group
Number of subjects: 56
Study 27157032 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD load individuals
Number of subjects: 56
Study 24076296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic denervation assessed using (11)C‐HED PET
Number of subjects: 204
Study 24076296 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of all 4 risk factors (PET sympathetic denervation, left ventricular end‐diastolic volume index, creatinine, and no angiotensin inhibition)
Number of subjects: 204
Study 24076296 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of ≥2 risk factors
Number of subjects: 204
Study 22705951 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal and iliohypogastric nerve block with 20 mL bupivacaine 0.5%
Number of subjects: 60
Study 22705951 — intervention group
Group type: COMPARATOR
Intervention: Placebo block with 20 mL saline
Number of subjects: 60
Study 20038957 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel and thalidomide
Number of subjects: 0
Study 20038957 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 0
Study 17563148 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 146
Study 17563148 — intervention group
Group type: COMPARATOR
Intervention: Control (smoking cessation plus weight control without exercise)
Number of subjects: 146
Study 16282298 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (400 microg/kg)
Number of subjects: 46
Study 16282298 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) (6 mg/kg)
Number of subjects: 46
Study 12011121 — intervention group
Group type: EXPERIMENTAL
Intervention: Aza C (75 mg/m² subcutaneous for 7 days every 4 weeks)
Number of subjects: 191
Study 12011121 — intervention group
Group type: COMPARATOR
Intervention: Aza C
Number of subjects: 191
Study 10745332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin G (IVIG) 1 g/kg on three consecutive days
Number of subjects: 58
Study 10745332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 7874928 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered-dose inhaler (MDI) - 400 micrograms of albuterol
Number of subjects: 19
Study 7874928 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotahaler - 400 micrograms of albuterol
Number of subjects: 19
Study 7874928 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskhaler - 400 micrograms of albuterol
Number of subjects: 19
Study 7874928 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI in asthmatic subjects
Number of subjects: 19
Study 7874928 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskhaler in asthmatic subjects
Number of subjects: 19
Study 7874928 — intervention group
Group type: COMPARATOR
Intervention: MDI and Diskhaler
Number of subjects: 19
Study 2211570 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (mean dose 41-54 mg/day from Week 2 to end of study)
Number of subjects: 140
Study 2211570 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (for melancholic patients)
Number of subjects: 140
Study 2211570 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 140
Study 2211570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 347099 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone for 3 days
Number of subjects: 60
Study 347099 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized gentamicin for 10 days
Number of subjects: 60